-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Tenax Therapeutics with Overweight Rating, Announces Price Target of $35

Benzinga·03/17/2026 12:40:33
Listen to the news
Cantor Fitzgerald analyst Olivia Brayer Saunders initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Overweight rating and announces Price Target of $35.